Evidence map›Paper›PMID 27842865›Full record

ReviewJournal of global antimicrobial resistance2015

Monitoring the efficacy of drugs for neglected tropical diseases controlled by preventive chemotherapy.

M Albonico, B Levecke, P T LoVerde, A Montresor, R Prichard, J Vercruysse, J P Webster

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of global antimicrobial resistance, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Survey Design to Monitor Drug Efficacy for the Control of Soil-Transmitted Helminthiasis and Schistosomiasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Review
  11. Review
  12. NTD Diagnostics for Disease Elimination: A Review.Diagnostics (Basel, Switzerland) · 2020
    Review
  13. Effect of Praziquantel onPathogens (Basel, Switzerland) · 2020
    Article
  14. Review
  15. Emerging Resistance of Neglected Tropical Diseases: A Scoping Review of the Literature.International journal of environmental research and public health · 2019
    Article
  16. Genetic Markers of Benzimidazole Resistance among Human Hookworms (The American journal of tropical medicine and hygiene · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Preventive chemotherapy to control soil-transmitted helminthiasis averted more than 500 000 DALYs in 2015.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 6 countries.

M AlbonicoFondazione Ivo de Carneri, via IV Marzo 14, 10122 Torino, Italy. Electronic address: albonico@tin.it.
B LeveckeLaboratory of Parasitology, Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
P T LoVerdeDepartments of Biochemistry and Pathology, University of Texas Health Science Center, 7703 Floyd Curl Dr., MS7760, San Antonio, TX 78229-3900, USA.
A MontresorDepartment of Control of Neglected Tropical Diseases, World Health Organization, Avenue Appia 20, CH-1211 Geneva, Switzerland.
R PrichardInstitute of Parasitology, McGill University, Macdonald Campus, 21 111 Lakeshore Road, St Anne-de-Bellevue, QC, Canada H9X 3V9.
J VercruysseLaboratory of Parasitology, Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
J P WebsterDepartment of Pathology and Pathogen Biology, Centre for Emerging, Endemic and Exotic Diseases (CEEED), Royal Veterinary College, University of London, Hawkshead Campus, North Mymms AL9 7TA, UK; Department of Infectious Disease Epidemiology, School of Public Health, St Mary's Hospital, Imperial College Faculty of Medicine, London W2 1PG, UK.
Ghent University · BEInstitute for Scientific Interchange · ITMcGill University · CAThe University of Texas Health Science Center at San Antonio · USUniversity of London · GBWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

In the last decade, pharmaceutical companies, governments and global health organisations under the leadership of the World Health Organization (WHO) have pledged large-scale donations of anthelmintic drugs, including ivermectin (IVM), praziquantel (PZQ), albendazole (ALB) and mebendazole (MEB). This worldwide scale-up in drug donations calls for strong monitoring systems to detect any changes in anthelmintic drug efficacy. This review reports on the outcome of the WHO Global Working Group on Monitoring of Neglected Tropical Diseases Drug Efficacy, which consists of three subgroups: (i) soil-transmitted helminthiases (ALB and MEB); (ii) onchocerciasis and lymphatic filariasis (IVM); and (iii) schistosomiasis (PZQ). Progress of ongoing work, challenges and research needs for each of the four main drugs used in helminthic preventive chemotherapy (PC) are reported, laying the ground for appropriate implementation of drug efficacy monitoring programmes under the co-ordination and guidelines of the WHO. Best practices for monitoring drug efficacy should be made available and capacity built as an integral part of neglected tropical disease (NTD) programme monitoring. Development of a disease-specific model to predict the impact of PC programmes, to detect outliers and to solicit responses is essential. Research studies on genetic polymorphisms in relation to low-efficacy phenotypes should be carried out to identify markers of putative resistance against all NTD drugs and ultimately to develop diagnostic assays. Development of combination and co-administration of NTD drugs as well as of new drug entities to boost the armamentarium of the few drugs available for NTD control and elimination should be pursued in parallel.

Indexed as

Anthelmintic drugsDrug efficacyDrug resistanceMonitoring

Identifiers

PMID27842865
PMCPMC5642864
OpenAlexW2179012861

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.